StockNews.com downgraded shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) from a hold rating to a sell rating in a research report released on Saturday. Other research analysts have also recently issued reports about the company. Oppenheimer boosted their price target on Corbus Pharmaceuticals from $58.00 to $60.00 and gave the stock an outperform rating […]
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report)’s share price hit a new 52-week high on Tuesday . The stock traded as high as $50.30 and last traded at $50.00, with a volume of 58166 shares trading hands. The stock had previously closed at $48.55. Analyst Upgrades and Downgrades Several equities analysts recently weighed […]
StockNews.com upgraded shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) from a sell rating to a hold rating in a research note issued to investors on Saturday morning. Separately, Oppenheimer upped their price objective on shares of Corbus Pharmaceuticals from $20.00 to $51.00 and gave the company an outperform rating in a research note on […]